Das Flavonoid Quercetin

Zusammenfassung

Quercetin gehört zur Gruppe der Flavonoide, die v. a. in Obst, Blatt- und Wurzelgemüse sowie einigen Getreidesorten enthalten sind. Sie weisen antioxidative, antiinflammatorische, antikanzerogene, endothelprotektive sowie immunmodulierende Eigenschaften auf.

Wissenschaftliche Untersuchungen in vitro und in vivo weisen auf präventive und therapeutische Wirkungen von Quercetin hin: u. a. zur Kardioprotektion, bei chronisch entzündlichen Darmerkrankungen, Allergien und Entzündungen, zur Tumorprotektion, bei Diabetes, venösen Erkrankungen sowie viralen Atemwegserkrankungen.

Schlüsselwörter

Quercetin - Flavonoid - Antioxidans

Publikationsverlauf

Artikel online veröffentlicht:
14. Oktober 2020

• Literatur

• 1 Frankel EN, Kanner J, German JB. et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341 (8843): 454-457
• 2 Novoozi M, Angerson WJ, Lean ME. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 1998; 67: 1210-1218
• 3 Petrakis PL. et al. Metabolic studies of quercetin labeled with C¹⁴ . Archive of Biochemistry and Biophysiology 1959; 85: 264-271
• 4 Hollmann PCH. et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995; 62: 1276-1282
• 5 Frankel EN. et al. Inhibition of oxidation of human low-densty lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457
• 6 Luo M, Kannar K. et al. Inhibition of LDL oxidation by green tea extract. Lancet 1997; 349 (9048): 360-361
• 7 Chen L, Li J, Luo C. et al. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): Structure-activity relationship studies reveal salient pharmacophore features. Bioorg Med Chem 2006; 14 (24) : 8295-8306
• 8 Seri J, Suwon K, Dong Hae S. et al. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 2020; 35 (01) : 145-151
• 9 Yi L, Li Z, Yuan K. et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 2004; 78 (20) : 11334-11339
• 10 Zhang L, Lin D, Sun X. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science 2020; 368: 409-412
• 11 Onal H. The possible effect of quercetin on prophylaxis and treatment of COVID-19. Clinical Trials.gov; 2020
• 12 Hertog MGL, Feskens EJM. et al. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study. Lancet 1993; 342: 1007-1011
• 13 Zhu QY, Huang Y, Chen ZY. Interaction between flavonoids and α-tocopherol in human low density lipoprotein – The Zutphen Elderly study. J Nutr Biochemistry 2000; 11 (01) : 14-21
• 14 Morales M, Lozoya X. Calcium-antagonist effect of quercetin on aortic smooth muscle. Planta Medica 1994; 60 (04) : 313-317
• 15 Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammmatory bowel disease. Gastroenterology 1984; 86: 453-460
• 16 Schneider H, Simmering R. et al. Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol 2000; 89 (06) : 1027-1037
• 17 Jacobasch G, Schmiedl D. et al. Dietary resistant starch and chronic inflammatory bowel diseases. Int J Colorectal Dis 1999; 14 (4–5): 201-211
• 18 Wachtershauser A, Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 2000; 39 (04) : 164-171
• 19 Pearce FL, Befus AD, Bienenstock J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol 1984; 73 (06) : 819-823
• 20 Busse WW. et al. Flavonoid modulation of human neutrophil function. J Allergy Clin Immunol 1984; 73: 801-809
• 21 Cruz T, Galvez J. et al. Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Science 1998; 62 (07) : 687-695
• 22 Segain JP. et al. Butyrate inhibits inflammatory responses through NF-κB inhibition: implications for Crohn’s disease. Gut 2000; 47 (03) : 397-403
• 23 Inan MS. et al. The luminal short-chain fatty acid butyrat modulates NF-κB activity in a human colonic epithelial cell line. Gastroenterol 2000; 118 (04) : 724-734
• 24 Scheppach W, Sommer H. et al. Effect of butyrat enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterol 1992; 103 (01) : 51-56
• 25 Ishikawa Y, Kitamura M. Bioflavonoid quercetin inhibits mitosis and apoptosis of glomerular cells in vitro and in vivo. Biochem Biophys Res Commun 2000; 279 (02) : 629-634
• 26 Le Marchand L, Murphy SP, Hankin JH. et al. Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000; 92 (02) : 154-160
• 27 Nishino H. et al. Role of flavonoids in suppressing the enhacement of phopholipid metabolism by tumor promoters. Cancer Letters 1983; 21: 1-8
• 28 Duthie SJ, Dobson VL. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur J Nutr 1999; 38 (01) : 28-34
• 29 Aherne SA, O‘Brien NM. Mechanism of protection by the flavonoids, quercetin and rutin, against tert-butylhydroperoxide- and menadione-induced DNA single strand breaks in Caco-2-cells. Free Radic Biol Med 2000; 29 (06) : 507-514
• 30 Novoozi M. et al. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 1998; 67: 1210-1218
• 31 Middleton E. et al. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol 1984; 33: 3333-3338
• 32 Yoshimoto T. et al. Flavonoids: Potent inhibitors of arachidonic 5-lipoxygenase. Biochem Biophys Res Commun 1983; 116: 612-618
• 33 Ferrandiz ML, Alcaraz MJ. Antiinflammatoriy activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Action 1991; 32: 283-287
• 34 Tarayre JP, Lauressergues H. Advantages of a combination of proteolytic enzymes, falvonoids and ascorbic acid in comparison with non-steroid anti-inflammatory agents. Arzneimittel Forschung 1977; 27: 1144-1149
• 35 Gröber U. Orthomolekulare Medizin. Ein Leitfaden für Apotheker und Ärzte. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1999
• 36 Chaundry PS. et al. Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin. Biochem Pharmacol 1983; 32: 1995-1998
• 37 Varma SD. et al. Diabetic cataracts and flavonoids. Science 1977; 195: 87-89
• 38 Kiesewetter H. et al. Buchweizenkraut-/Troxerutin-Kombination bei chronisch venöser Insuffizienz. Zeitschrift für Phytotherapie 1997; 18: 341-346
• 39 Neumann HAM, van den Broek MJTB. A comparative clinical trial of graduated compression stockings and O-(β-hydroxyethyl)-rutosides (HR) in the treatment of patients with chronic venous insufficiency. Lymphology 1995; 19: 8-11
• 40 Peres W, Tunon MJ. et al. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 2000; 33 (05) : 742-750